Evidence map›Paper›PMID 37110496›Full record

ArticleMicroorganisms2023

Characterization of a Riboflavin-Producing Mutant of

Fan Xu, Chuan Liu, Miaomiao Xia, Shixin Li, Ran Tu, Sijia Wang, Hongxing Jin, Dawei Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Engineering riboflavin-overproducingSynthetic and systems biotechnology · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fan XuSchool of Chemical Engineering, Hebei University of Technology, Tianjin 300131, China.
Chuan LiuTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
Miaomiao XiaTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
Shixin LiTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
Ran TuTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.
Sijia WangSchool of Biological Engineering, Dalian Polytechnic University, Dalian 116034, China.
Hongxing JinSchool of Chemical Engineering, Hebei University of Technology, Tianjin 300131, China.
Dawei ZhangTianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China.ORCID 0000-0002-5857-394X

Funding

National Key R&D Program of China 2021YFC2100700National Natural Science Foundation of China 22178372Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project TSBICIP-CXRC-055Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project TSBICIP-KJGG-004-03Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project TSBICIP-KJGG-011Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project TSBICIP-PTJJ-007Yellow River Delta Industry Leading Talents No.DYRC20190212
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Bacillus subtilisBioengineeringdroplet-based microfluidicsfermentationhigh-throughput screeningMolecular biologyriboflavin

Identifiers

PMID37110496
PMCPMC10146818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.